BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bordeaux Institute of Oncology - ECPv6.17.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.bricbordeaux.com/en/
X-WR-CALDESC:Events for Bordeaux Institute of Oncology
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230415
DTEND;VALUE=DATE:20230416
DTSTAMP:20230426T084148Z
CREATED:20230426T084148Z
LAST-MODIFIED:20230426T084148Z
UID:43226-1681516800-1681603199@www.bricbordeaux.com
SUMMARY:Samuel Amintas\, thesis prize asso NMS
DESCRIPTION:Dr Samuel Amintas\, university hospital practitioner (Bordeaux University Hospital)\, team 8 Biotherapies Genetics and Oncology BioGO\, was awarded the thesis prize of the Nutrition Méditerranée Santé (NMS) association headed by Professor Emeritus Norbert Latruffe\, during its General Assembly on April 15. \nHis thesis\, defended in June 2022\, had for subject: Radiosensitization of digestive tumors by bioactive food molecules.
URL:https://www.bricbordeaux.com/en/event/samuel-amintas-thesis-prize-asso-nms/
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/04/prix-de-these-samuel-amintas.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230426
DTEND;VALUE=DATE:20230427
DTSTAMP:20230428T082910Z
CREATED:20230426T082749Z
LAST-MODIFIED:20230428T082910Z
UID:43220-1682467200-1682553599@www.bricbordeaux.com
SUMMARY:Financing of the PORPHYRIA project by SATT Aquitaine
DESCRIPTION:SATT Aquitaine invests in the maturation of innovative projects from regional public research. SATT Aquitaine’s objective is to mature these inventions\, from the stage of research results to pre-industrialization (proof of concept)\, and to support them until they are brought to market. \nHead by Pr Emmanuel RICHARD\, PU-PH\, head of the biochemistry department at Bordeaux University Hospital and member of theteam 08 – Biotherapies Genetics and Oncology (BioGO)in collaboration with Dr Oscar MILLET of the CICBioGUNE \, Bilbao\, the project PORPHYRIA aims to develop a pharmacological therapeutic option for erythropoietic porphyrias\, a group of rare diseases of heme metabolism. The objective of the €568\,000 investment by SATT Aquitaine is to identify and validate in-vitro and in-vivo a pharmacological inhibitor of the ALAS2 enzyme\, previously identified as a therapeutic target by the BioGO team. \nMore information at this link
URL:https://www.bricbordeaux.com/en/event/financing-of-the-porphyria-project-by-satt-aquitaine/
CATEGORIES:News
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/04/financement-satt-biogo.png
END:VEVENT
END:VCALENDAR